The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have no benefit, but also been prescribed for 40 years. How is this possible? We need to start regulating Big Pharma and research urgently! https://t.co/iAYBPTNp1H
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Aug 2025 – Nov 2025Where it's discussed
-
News225 articles
-
X / Twitter182 posts
-
Blogs9 articles
-
Bluesky6 posts
-
YouTube3 videos
-
Facebook2 posts
AI synopsis
What people are saying
Several discussions actively highlight the study's key findings, noting that beta-blocker therapy showed no significant benefit for patients with preserved ejection fraction after a heart attack. Phrases like 'landmark study' and 'time to rethink routine use' underscore the urgency and importance of the findings, and the expression of skepticism towards long-standing practices showcases how the words and tone contribute to a call for reassessment in medical treatment strategies.
The majority of discussions reflect a general agreement with the study's conclusion that beta-blockers may not be necessary after myocardial infarction in certain patients.
There is a strong level of curiosity and relevance among posters, as many highlight the implications for clinical practice.
While some posts reference the study's details, others express a need for deeper insights, indicating moderate engagement with the content.
Users perceive this publication as potentially influential in changing long-held clinical practices surrounding beta-blocker prescriptions.
Abstract in brief
- The study aimed to evaluate the effectiveness of beta-blocker therapy in patients with acute myocardial infarction and a left ventricular ejection fraction above 40%, comparing it with a group receiving no beta-blockers.
- Over a median follow-up of 3.7 years involving 8438 patients, the findings indicated no significant difference in primary outcome events (death, reinfarction, hospitalization for heart failure) between the beta-blocker group and the no-beta-blocker group.
- The conclusion suggests that beta-blocker therapy may not provide additional benefits for patients who have undergone invasive treatment for myocardial infarction in this specific population.
Top posts
Most liked on X and BlueskyOriginal Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfnxKQ #ESCCongress | @escardio https://t.co/GW0dlMUHEJ
Vamos ao Reboot Trial, ou, no título original, "Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction" Esse estudo veio para tirar uma dúvida ancestral da cardiologia. Após um evento isquêmica com estratificação invasiva com CATE, vale a pena manter bbloqs?
Among patients with myocardial infarction and a left ventricular ejection fraction of more than 40%, beta-blockers did not lead to a lower incidence of death, reinfarction, or hospitalization for heart failure than no beta-blocker therapy. Full REBOOT trial results: nej.md/45QYbws
REBOOT trial
All mentions
Advances in Stroke Prevention for Atrial Fibrillation Patients
This video discusses recent research on left atrial appendage closure as a safe and effective alternative to anticoagulation in high-risk atrial fibrillation patients. It highlights reduced bleeding complications and…
Cardiovascular Screening Outcomes and Beta-Blocker Insights
This week, John Mandrola MD discusses key findings from the Danish Cardiovascular Screening Trial. The trial, involving over 46,000 men aged 65-74, showed no significant reduction in mortality but indicated lower rates…
Highlights of ESC 2025: Innovations in Heart Failure Treatments
In this video, Dr. Gabryely Dorner presents highlights from ESC 2025, focusing on significant trials such as Digitoxin in patients with heart failure and reduced ejection fraction. The study found digitoxin linked to…
Europea de Cardiología (ESC) y publicado en The New England Journal of Medicine (NEJM). https://t.co/UuluHKdD8H
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @EricTopol: Beta blockers were routinely given to patients after a heart attack. 2 new randomized trials show conflicting results for pa…
Post-MI with preserved EF (>40%)? Routine beta-blocker use may not be necessary. A large RCT found no benefit in reducing death, reinfarction, or HF hospitalization in patients who received modern invasive care. A key finding for daily practice. https://t.co/2vviW5hW3c
BETA BLOCKERS – STANDARD #TREATMENT 40 YEARS AFTER #heartattack NO #CLINICAL BENEFIT FOR PATIENTS – LANDMARK STUDY https://t.co/fD6B2qMBWY BETA BLOCKER #THERAPY NO EFFECT ON INCIDENCE OF #DEATH FROM ANY CAUSE https://t.co/XneUmAKuYv WOMEN WORSE OUTCOMES https://t.co/n99uS71ld3 https://t.co/u9yAdk8wzQ
RT @erlesen: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction https://t.co/7C1JiYkPdk https://t.co/TYFp4f1OtI Be…
RT @EricTopol: Beta blockers were routinely given to patients after a heart attack. 2 new randomized trials show conflicting results for pa…
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @afcisnal: 1/
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
REBOOT-CNIC trial: In patients with acute MI (STEMI and NSTEMI) managed with invasive care (92.1% with PCI) and LVEF>40% with no Hx of CHF, beta blockers (bisoprolol in 85.9%) did not reduce MACE vs. no beta blockers at 3.7 years. https://t.co/O1lGHCpQVF https://t.co/KCPRCukAxc
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction | New England Journal of Medicine https://t.co/f7OuPdEalz
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
RT @RealSamBrokken: The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have n…
The cholesterol paradigm and statins are proven useless. Now a control-study over 4 years shows béta-blockers to have no benefit, but also been prescribed for 40 years. How is this possible? We need to start regulating Big Pharma and research urgently! https://t.co/iAYBPTNp1H
RT @EricTopol: Beta blockers were routinely given to patients after a heart attack. 2 new randomized trials show conflicting results for pa…
Acceso artículo Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction Borja Ibanez et al. N Engl J Med. 2025. https://t.co/9bfyGuJ4aE
Among patients with myocardial infarction and a left ventricular ejection fraction of more than 40%, beta-blockers did not lead to a lower incidence of death, reinfarction, or hospitalization for heart failure than no beta-blocker therapy. Full REBOOT trial results: nej.md/45QYbws
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction | New England Journal of Medicine https://t.co/Nu8PVInuQF
RT @radcliffeCARDIO:
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction | New England Journal of Medicine https://t.co/wa38YjwwX6
RT @radcliffeCARDIO:
【RCT】LVEF40%以上の急性心筋梗塞患者へのβ遮断薬の投与は、投与なしと比較して、全原因死亡、再梗塞、心不全入院の複合転帰を減少させなかった。 #ペ読 https://t.co/AFcvhgVVDI
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction www.nejm.org/doi/full/10.... www.nejm.org/doi/full/10.... Betablocker können lebensgefährlich sein. Allein in Deutschland nehmen nach Schätzungen 5,5 Millionen täglich Betablocker ein www.t-online.de/gesundheit/a...
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction https://t.co/7C1JiYkPdk https://t.co/TYFp4f1OtI Betablocker können lebensgefährlich sein. Allein in Deutschland nehmen nach Schätzungen 5,5 Millionen täglich Betablocker ein https://t.co/DOrP9Xnmy0
@alinefortuna2 e pode aumentar chance de infarto dependo de certos fatores https://t.co/zu7fxvHSkF https://t.co/Ajbv4qmbjT
BETAMI–DANBLOCK試験
REBOOT trial
Ref) Beta-Blockers after MI + LVEF >40% ・BETAMI–DANBLOCK https://t.co/IyxX2MFuiL ・REBOOT-CNIC https://t.co/5jwigx12Ni ・Meta-analysis (LVEF 40-49%) https://t.co/Nt3gK00VBU #ESCCongress #ESC2025 #CardioTwitter
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction | New England Journal of Medicine https://t.co/DZ8t2Ay1yE
RT @Carcos2: El envés y el revés. No es que sorprenda, pero qué difícil es tomar decisiones en pacientes individuales en un entorno, aún in…
El envés y el revés. No es que sorprenda, pero qué difícil es tomar decisiones en pacientes individuales en un entorno, aún informado, plagado de incertidumbre https://t.co/yxWVzr26kB https://t.co/mLcUPeXTEW https://t.co/UAr2iu25rs
LVEF>40%の心筋梗塞患者8438人を対象としたスペインとイタリアのRCT(REBOOT-CNIC)では,β遮断薬投与は非投与と比べて総死亡+再梗塞+心不全入院を減らさなかった(HR 1.04,0.89~1.22,追跡中央値3.7年). https://t.co/PgcD6iSWo3
Link do trial: https://t.co/jvpfGwnr3W Dá pra acessar gratuitamente tendo uma conta. Tenho o PDF, se alguém quiser me chama que mando
Vamos ao Reboot Trial, ou, no título original, "Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction" Esse estudo veio para tirar uma dúvida ancestral da cardiologia. Após um evento isquêmica com estratificação invasiva com CATE, vale a pena manter bbloqs?
Link to paper https://t.co/MrGOrJqNmu
RT @afcisnal: 1/
@tamara_gindin @New_Man_tm אם כבר, זו דוווקא דוגמא לאיך הדברים צריכים להיראות. לבדוק אם הפרדיגמות הישנות עומדות במבחן הזמן. כאן המחקר Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction | New England Journal of Medicine https://t.co/UTFWtq9F7M
RT @EricTopol: Beta blockers were routinely given to patients after a heart attack. 2 new randomized trials show conflicting results for pa…
RT @EricTopol: Beta blockers were routinely given to patients after a heart attack. 2 new randomized trials show conflicting results for pa…
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction | New England Journal of Medicine https://t.co/7JvooSL28q
'Among patients discharged after invasive care for a myocardial infarction with a left ventricular ejection fraction above 40%, beta-blocker therapy appeared to have no effect on the incidence of death from any cause.' https://t.co/ZLH2uu8CTE
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction #science #publication #research #publications https://t.co/2LJIRJm59E
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
Tried to find the actual article but I don’t have access: https://t.co/sFHFcM4LQ4 I’m on a beta blocker as part of my heart failure meds so would really like to know more… https://t.co/wnEELAdI2U
@CovidSolidarit1 https://t.co/slJvdfs1Uk
REBOOT trial
REBOOT trial
RT @roca_ferran:
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
3/ La clave es el ensayo REBOOT, con 8.500 pacientes. Sus resultados en infartos no complicados: "Beta-blocker therapy appeared to have NO EFFECT on the incidence of death from any cause, reinfarction, or hospitalization for heart failure". Fuente: @NEJM https://t.co/cE3MP7vOCR
RT @EricTopol: Beta blockers were routinely given to patients after a heart attack. 2 new randomized trials show conflicting results for pa…
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
RT @ESC_Journals: Simultaneous publication during #ESCCongress Sex differences in the effect of beta blockers after myocardial infarction…
RT @ESC_Journals: Simultaneous publication during #ESCCongress Sex differences in the effect of beta blockers after myocardial infarction…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @gunnar_heine: Beta Blocker after AMI without HFREF. https://t.co/M0KNNr01zM https://t.co/iaQXTrrKEt No benefit in Mediterranean Countri…
RT @EricTopol: Beta blockers were routinely given to patients after a heart attack. 2 new randomized trials show conflicting results for pa…
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction | New England Journal of Medicine https://t.co/hkIMQC1cd0
#ESC2025 trials (REBOOT-CNIC & BETAMI-DANBLOCK) clash on beta-blockers post-heart attack for EF>40%. REBOOT: no benefit; BETAMI: 15% lower risk. Time to rethink routine use? Details: https://t.co/nKtuMsnMQL #Cardiology #ClinicalTrials @safinmc
RT @SeguraCardio:
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @EricTopol: Beta blockers were routinely given to patients after a heart attack. 2 new randomized trials show conflicting results for pa…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
Desde hace 40 años, >80% de pacientes con IAM no complicado se dan de alta con BETABLOQUEADORES, REBOOT Trial acaba de demostrar que posinfartados con FEVI normal no necesitan betabloqueadores… https://t.co/f44SlQjYJF
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
RT @EricTopol: Beta blockers were routinely given to patients after a heart attack. 2 new randomized trials show conflicting results for pa…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @jvillacastin: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction | New England Journal of Medicine https://t.c…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
"Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction", New England Journal of Medicine (2025). @PKatchunga @CCikomola
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
RT @SeguraCardio:
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @ehealthmgmt: REBOOT Trial: In patients discharged after invasive care for myocardial infarction with LVEF above 40%, beta-blocker thera…
RT @ehealthmgmt: REBOOT Trial: In patients discharged after invasive care for myocardial infarction with LVEF above 40%, beta-blocker thera…
REBOOT Trial: In patients discharged after invasive care for myocardial infarction with LVEF above 40%, beta-blocker therapy had no effect on incidence of death, reinfarction, or hospitalisation for heart failure. Read more: https://t.co/PWQn8xyXDe #ESCCongress
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @ESC_Journals: Simultaneous publication during #ESCCongress Sex differences in the effect of beta blockers after myocardial infarction…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @SeguraCardio:
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
RT @ESC_Journals: Simultaneous publication during #ESCCongress Sex differences in the effect of beta blockers after myocardial infarction…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @ESC_Journals: Simultaneous publication during #ESCCongress Sex differences in the effect of beta blockers after myocardial infarction…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
RT @NEJM: Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfn…
Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) https://t.co/mgegnfnxKQ #ESCCongress | @escardio https://t.co/GW0dlMUHEJ
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
RT @ESC_Journals: Simultaneous publication during #ESCCongress Sex differences in the effect of beta blockers after myocardial infarction…
RT @ESC_Journals: Simultaneous publication during #ESCCongress Sex differences in the effect of beta blockers after myocardial infarction…
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction | New England Journal of Medicine https://t.co/JdzCZ01biC
RT @ESC_Journals: Simultaneous publication during #ESCCongress Sex differences in the effect of beta blockers after myocardial infarction…
RT @ESC_Journals: Simultaneous publication during #ESCCongress Sex differences in the effect of beta blockers after myocardial infarction…
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
RT @a_elaskary81: 2025 Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction #nejm https://t.co/sJWI22rGon https://t…
2025 Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction #nejm https://t.co/sJWI22rGon https://t.co/8JrgR0BKIA
RT @SeguraCardio:
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
RT @ESC_Journals: Simultaneous publication during #ESCCongress Sex differences in the effect of beta blockers after myocardial infarction…
RT @ESC_Journals: Simultaneous publication during #ESCCongress Sex differences in the effect of beta blockers after myocardial infarction…
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction | NEJM #ESCCongress Change Practice Please: Stop B-blocker post MI if EF is preserved. https://t.co/IS1jjwVJIT https://t.co/6PaOg3GJEh
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
RT @DrDamluji: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: @NEJM #ESCCongress2025
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy (MAPLE-HCM Phase 3 trial) nej.md/45zDWo3 Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) nej.md/45QYbws
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction www.nejm.org/doi/full/10....
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction. www.nejm.org/doi/full/10.... @nejm.org @escardio.bsky.social #CardioSky #ESCCongress #WCCardio
After a heart attack, women shown to have worse prognosis when treated with beta-blockers Credit: CC0 Public Domain A major new analysis from the REBOOT (Treatment with Beta-blockers after Myocardial Infarction without Reduced Ejection Fraction) clinical trial, an international study coordinated…